The U.S. Food and Drug Administration authorized four NJOY products through the Premarket Tobacco Products Application (PMTA) process on April 26. The FDA issued a marketing approval order to NJOY, Awarded the Ace Enclosed e-cigarette device and three accompanying tobacco-flavored e-cigarette bombs -- NJOY Ace Pod Classic Tobacco 2.4%, NJOY Ace Pod Classic Tobacco 5% and NJOY Ace Pod Rich Tobacco 5%
At the same time, FDA issued NJOY a marketing rejection order for a variety of other Ace e-cigarette products, which must now be removed from the market. Applications for two mint-flavored Ace e-cigarette oils are still under FDA review.
Under the PMTA pathway, applicants must demonstrate to the agency, among other things, that the marketing of new tobacco products will be appropriate to protect public health, the FDA explained in a statement. Licensed NJOY products meet this standard because, among several key considerations, chemical testing is sufficient to determine that the levels of total hazardous and potentially hazardous components (HPHC) in aerosols of these products are lower than those in burnt cigarette smoke.
In addition, data provided by the applicants indicated that participants who used only licensed NJOY Ace products had lower levels of exposure to HPHC compared to dual users of new products and burning cigarettes. Thus, these products have the potential to benefit adult smokers who completely or significantly reduce their cigarette consumption.
In addition, the FDA considered the risks and benefits to the entire population, including users and non-users of tobacco products, especially young people. This includes reviewing existing data on young people's likelihood of using the product. For licensed products, FDA determined that the potential benefits to adult smokers of complete or significant reduction in smoking would outweigh the risks to adolescents if the company complied with post-marketing requirements to reduce adolescent exposure to cigarettes and adolescent exposure to cigarettes. Marketing.
In addition, the authorization imposes strict marketing restrictions on companies to greatly reduce the likelihood that teens will be exposed to tobacco advertising for these products. The FDA said it will closely monitor how these products are marketed and will take necessary action if companies fail to comply with any applicable legal or regulatory requirements or if the number of nonsmokers, including adolescents, increases significantly.

